Innovative Data Platform Ultromics utilizes a cutting-edge AI-powered platform, EchoGo®, which leverages the largest known dataset in echocardiography to improve heart failure diagnosis, presenting opportunities to collaborate with hospitals seeking advanced diagnostic tools.

Strong Funding & Partnerships Recent $55 million Series C funding, backed by major healthcare institutions like UChicago Medicine and UPMC Enterprises, signifies growing investor confidence and potential for scaling sales efforts within major U.S. health systems.

Recognition & Industry Presence Recognition as a Wired 2025 Trailblazer and inclusion in the Future Fifty Forum highlight Ultromics’ innovative leadership in healthcare technology, making it an ideal partner for early adopters and forward-thinking medical institutions.

Market Focus & Expansion Targeting complex cardiac diseases such as HFpEF with AI diagnostics positions Ultromics to expand into hospitals and clinics aiming to enhance early detection and treatment of heart failure, especially those invested in precision medicine.

Growing Clinical Collaborations Partnerships with renowned organizations like Mayo Clinic, Johnson & Johnson, and Pfizer provide sales channels to access top-tier healthcare providers actively integrating innovative cardiac diagnostics into their practice.